Founder's Award to Robert S. Langer, D.Sc., 2013 Society for Biomaterials Annual Meeting and Exposition, Boston, Massachusetts, April 10-12, 2013.
Biomaterials and biotechnology: From the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering
Article first published online: 28 JUN 2013
Copyright © 2013 Wiley Periodicals, Inc.
Journal of Biomedical Materials Research Part A
Volume 101A, Issue 9, pages 2449–2455, September 2013
How to Cite
How to cite this article: 2013. Biomaterials and biotechnology: From the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering. J Biomed Mater Res Part A 2013:101A: 2449–2455..
- Issue published online: 22 JUL 2013
- Article first published online: 28 JUN 2013
- Accepted manuscript online: 31 MAY 2013 03:51AM EST
- Manuscript Accepted: 20 MAY 2013
- Manuscript Received: 10 MAY 2013
- drug delivery;
This paper describes the discovery of the first inhibitors of angiogenesis; the discoveries that led to the development of the first biocompatible controlled release systems for macromolecules, and findings that helped to create the field of tissue engineering. In addition, new paradigms for creating biomaterials, early work on nanotechnology in medicine and intelligent drug delivery systems are discussed. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 2449–2455, 2013.